Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill aims to tackle high blood pressure in overweight patients

NCT ID NCT07528027

First seen Apr 26, 2026 · Last updated May 23, 2026 · Updated 8 times

Summary

This study tests an experimental drug called HRS-7535 to see if it can lower blood pressure better than a placebo in adults aged 18-70 who have both high blood pressure and overweight or obesity. About 648 participants will take the drug or a dummy pill for up to 48 weeks. The main goal is to check blood pressure changes at 24 weeks, with additional measures like weight and cholesterol changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION WITH OVERWEIGHT OR OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Peking University First Hospital

    Beijing, Beijing Municipality, 100034, China

    Contact

  • The First Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, 163711, China

    Contact

Conditions

Explore the condition pages connected to this study.